Discover
TNDM
Tandem Diabetes Care, Inc.
15.75
1 x 15.69
2 x 19.39
bid
ask
+
0.66
4.37%
2 @ 04:12 AM
15.55 -0.20 (1.27%)
| Ytd | -28.34% | |
| 1y | -7.79% |
15.10
day range
15.77
9.98
52 week range
29.65
| Open | 15.10 | Prev Close | 15.09 | Low | 15.10 | High | 15.77 | Mkt Cap | 1.08B |
| Vol | 1.30M | Avg Vol | 2.37M | EPS | -1.37 | P/E | N/A | Forward P/E | 194.01 |
| Beta | 1.57 | Short Ratio | 3.69 | Inst. Own | 117.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 16.83 | 200-d Avg | 18.64 | 1yr Est | 28.88 |
| Income Statement | |||
| Total Revenue | 247.22M | ||
| Revenues (USD) | 247.22M | ||
| Cost of Revenue | 110.43M | ||
| Gross Profit | 136.79M | ||
| Operating Expenses | 154.22M | ||
| Research and Development Expense | 46.04M | ||
| Selling, General and Administrative Expense | 108.19M | ||
| Operating Income | -17.43M | ||
| Interest Expense | 2.20M | ||
| Income Tax Expense | 516.00K | ||
| Net Income | -20.39M | ||
| Net Income Common Stock | -20.39M | ||
| Net Income Common Stock (USD) | -20.39M | ||
| Consolidated Income | -20.39M | ||
| Earnings per Basic Share | -0.30 | ||
| Earnings per Basic Share (USD) | -0.30 | ||
| Earnings per Diluted Share | -0.30 | ||
| Earning Before Interest & Taxes (EBIT) | -17.67M | ||
| Earning Before Interest & Taxes (USD) | -17.67M | ||
| Weighted Average Shares | 68.40M | ||
| Weighted Average Shares Diluted | 68.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 179.33M | ||
| Cash and Equivalents (USD) | 179.33M | ||
| Investments | 447.42M | ||
| Investments Current | 390.93M | ||
| Investments Non-Current | 56.49M | ||
| Trade and Non-Trade Receivables | 140.67M | ||
| Current Assets | 887.10M | ||
| Property, Plant & Equipment Net | 178.99M | ||
| Total Assets | 1.15B | ||
| Debt Current | 20.11M | ||
| Total Debt | 734.74M | ||
| Current Liabilities | 247.96M | ||
| Debt Non-Current | 714.63M | ||
| Total Liabilities | 1.02B | ||
| Accumulated Retained Earnings (Deficit) | -1.27B | ||
| Accumulated Other Comprehensive Income | 5.04M | ||
| Shareholders Equity | 132.40M | ||
| Shareholders Equity (USD) | 132.40M | ||
| Assets Non-Current | 266.29M | ||
| Total Debt (USD) | 734.74M | ||
| Deferred Revenue | 16.95M | ||
| Inventory | 126.40M | ||
| Liabilities Non-Current | 773.03M | ||
| Trade and Non-Trade Payables | 59.86M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.50M | ||
| Net Cash Flow from Financing | 274.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 88.69M | ||
| Capital Expenditure | -6.27M | ||
| Issuance (Repayment) of Debt Securities | 275.86M | ||
| Net Cash Flow from Investing | -195.45M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -189.18M | ||
| Net Cash Flow from Operations | 11.05M | ||
| Effect of Exchange Rate Changes on Cash | -1.08M | ||
| Share Based Compensation | 15.66M | ||